Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fattizzo

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|October 23, 2013
Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progressionWilma Barcellini, Francesca G Imperiali, Anna Zaninoni, et al.
International Journal of Molecular Sciences|August 29, 2024
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow FunctionJeff Szer, Jens Panse, Austin Kulasekararaj, et al.
Leukemia Research|October 2, 2013
Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patternsWilma Barcellini, Alessandra Iurlo, Tommaso Radice, et al.
Blood Transfusion = Trasfusione Del Sangue|December 29, 2022
Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune featuresBruno Fattizzo, Fabio Serpenti, Francesco Versino, et al.
Frontiers in Immunology|October 5, 2023
Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gapsFemke V M Mulder, Dorothea Evers, Masja de Haas, et al.
Blood|November 1, 2024
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemiaEloy Roman, Bruno Fattizzo, Merrill Shum, et al.
Frontiers in Oncology|April 8, 2022
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center ExperienceBruno Fattizzo, Giorgia Virginia Levati, Juri Alessandro Giannotta, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic IssuesValeria Cortesi, Francesca Manzoni, Genny Raffaeli, et al.
Signal Transduction and Targeted Therapy|August 25, 2025
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencingBruno Fattizzo, Matteo Claudio Da Vià, Francesca Lazzaroni, et al.
Blood|January 24, 2012
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|October 23, 2013
Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progressionWilma Barcellini, Francesca G Imperiali, Anna Zaninoni, et al.
International Journal of Molecular Sciences|August 29, 2024
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow FunctionJeff Szer, Jens Panse, Austin Kulasekararaj, et al.
Leukemia Research|October 2, 2013
Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patternsWilma Barcellini, Alessandra Iurlo, Tommaso Radice, et al.
Blood Transfusion = Trasfusione Del Sangue|December 29, 2022
Use of steroids in the management of low-risk myelodysplastic syndromes with autoimmune featuresBruno Fattizzo, Fabio Serpenti, Francesco Versino, et al.
Frontiers in Immunology|October 5, 2023
Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gapsFemke V M Mulder, Dorothea Evers, Masja de Haas, et al.
Blood|November 1, 2024
Safety and efficacy of pegcetacoplan treatment for cold agglutinin disease and warm antibody autoimmune hemolytic anemiaEloy Roman, Bruno Fattizzo, Merrill Shum, et al.
Frontiers in Oncology|April 8, 2022
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center ExperienceBruno Fattizzo, Giorgia Virginia Levati, Juri Alessandro Giannotta, et al.
Diagnostics (Basel, Switzerland)|September 28, 2021
Severe Presentation of Congenital Hemolytic Anemias in the Neonatal Age: Diagnostic and Therapeutic IssuesValeria Cortesi, Francesca Manzoni, Genny Raffaeli, et al.
Signal Transduction and Targeted Therapy|August 25, 2025
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencingBruno Fattizzo, Matteo Claudio Da Vià, Francesca Lazzaroni, et al.
Blood|January 24, 2012
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Pageof 14